SpaceX IPO Could Be A Rerating Catalyst For Rocket Lab

Rocket Lab is rated Buy with a $196 price target, implying 37% upside from the current $143 share price. The valuation is based on a 50x forward EV/Sales multiple and $2.35 billion of estimated revenue, with catalysts cited from AI-driven space-data demand, increased sovereign space spending, and a potential SpaceX IPO repricing the sector.

Analysis

RKLB is increasingly a capital-markets proxy for the entire “sovereign space stack,” and that matters because public-market re-rating can happen before fundamentals inflect. If the SpaceX IPO lands at a rich multiple, the first-order move may not be in the new listing itself but in adjacent public names with cleaner governance and easier index inclusion; RKLB is well positioned to absorb that incremental flow. The second-order winner is likely the industrial ecosystem around launch hardware, RF components, radiation-tolerant semis, and ground infrastructure as procurement budgets broaden from pure launch to persistent orbital services.

The biggest medium-term upside catalyst is not launch cadence alone; it is contract duration and mix shift. If AI-driven demand pushes customers toward recurring space-based data products, investors will start capitalizing backlog more like software-infrastructure than project aerospace, which can justify a much higher multiple even before margin expansion is obvious. That said, the market may be underestimating execution drag from Neutron’s timing: any slip turns the stock into a sentiment vehicle, where a few quarters of schedule disappointment can erase multiple expansion faster than revenue growth can replenish it.

The main contrarian risk is that the current enthusiasm compresses expected returns by bringing forward the valuation rerate before the operating leverage arrives. At these levels, RKLB likely trades on “category winner” status; if the broader space trade cools post-IPO or if sovereign spending stays fragmented rather than scaling into large multi-year awards, the stock can derate 20-30% without a true fundamental break. The setup is best viewed as a months-to-years thesis, but tactically it has event risk around launch milestones, contract announcements, and any SpaceX IPO pricing that disappoints relative to hype.

Key Decisions for Investors

• Stay long RKLB, but size it as a catalyst-driven compounder rather than a low-volatility core holding; best risk/reward is on pullbacks of 8-12% after sector-wide tape weakness, with a 3-6 month horizon.
• Pair trade: long RKLB / short a basket of lower-growth aerospace incumbents over the next 2-4 quarters to express relative multiple expansion from sovereign-space and data-infrastructure optionality.
• Buy medium-dated RKLB call spreads into any confirmed SpaceX IPO pricing window; upside is likely to front-run the listing by weeks, while spreads cap theta bleed if the IPO enthusiasm fades.
• If Neutron schedule slips or guidance is pushed out, reduce exposure quickly: the stock can reprice 20%+ on timing misses because the market is paying for execution credibility, not just TAM.
• Watch for a better entry in adjacent suppliers tied to orbital systems and secure communications; these names may lag the headline re-rate but offer cleaner downside if the broader space valuation trade becomes crowded.